Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post-operative recurrent pulmonary pleomorphic carcinoma.
Respirol Case Rep
; 9(6): e00781, 2021 Jun.
Article
en En
| MEDLINE
| ID: mdl-34012549
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Respirol Case Rep
Año:
2021
Tipo del documento:
Article